EADV 2022: Atopic Dermatitis in Pediatric Patients: Impact and Perspectives
Highlights from the EADV 2020 ADVENT symposium, exploring burden, management and the therapeutic landscape for pediatric atopic dermatitis.
On demand materials
Learning objectives
- Review data on the impact of atopic dermatitis on children and caregivers
- Overview of the current treatment landscape for atopic dermatitis in children, and the consequences of inadequate control
- Explore emerging clinical trial and real-world data for systemic therapies approved for children with atopic dermatitis, and review their impact
Description
Atopic dermatitis imposes significant burden on pediatric patients, spurring research for innovative therapies in the evolving treatment landscape. In this ADVENT-sponsored symposium at the EADV 2022 Congress in Milan, experts Michael J. Cork, BSc, MB, PhD, FRCP (University of Sheffield), Paolo Amerio, MD, PhD (University of Chieti-Pescara, Italy), and Anna Belloni Fortina, MD (Padova University), discussed the burden of atopic dermatitis on children and their caregivers, reviewed the current management standard for caring for pediatric atopic dermatitis, and delved into the implications of the emerging systemic treatment landscape for practicing dermatologists.
About these experts
